Paragon Bioservices

Paragon Bioservices, Inc. is a contract development and manufacturing organization headquartered in Baltimore, Maryland, specializing in the development and production of biopharmaceuticals. The company focuses on a range of advanced therapeutic products, including viral vector-based gene therapies, next-generation vaccines, monoclonal antibodies, and recombinant proteins. Paragon offers comprehensive services that encompass process and analytical development, as well as cGMP manufacturing and testing for pre-clinical and early clinical stages. With a commitment to innovation, Paragon has transitioned its client base from primarily government contracts to a strong emphasis on commercial partnerships within the biotech industry. The company's leadership team, composed of experienced professionals with over 20 years in the field, supports its mission to deliver high-quality manufacturing solutions. Paragon operates from a state-of-the-art facility that spans 150,000 square feet, providing the infrastructure necessary for the complete lifecycle of biopharmaceutical manufacturing, from initial development through to commercial launch.